Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. [electronic resource]
Producer: 19971023Description: 897-900 p. digitalISSN:- 0041-1337
- Abatacept
- Animals
- Antigens, CD
- Antigens, Differentiation -- therapeutic use
- Antilymphocyte Serum -- therapeutic use
- Bone Marrow Transplantation -- immunology
- CTLA-4 Antigen
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Graft Survival -- drug effects
- Histocompatibility Testing
- Immunization, Passive
- Immunoconjugates
- Immunosuppression Therapy -- methods
- Immunosuppressive Agents -- therapeutic use
- Mice
- Mice, Inbred AKR
- Mice, Inbred C3H
- Mice, Inbred C57BL
- Polyenes -- therapeutic use
- Sirolimus
- Skin Transplantation -- immunology
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.